<scp>IL</scp>‐33 attenuates EAE by suppressing <scp>IL</scp>‐17 and <scp>IFN</scp>‐γ production and inducing alternatively activated macrophages
Hui‐Rong Jiang(University of Strathclyde), Foo Y. Liew(King Abdulaziz University), Wanda Niedbała(University of Glasgow), Anne‐Galle Besnard(University of Glasgow), Marija Milovanović(University of Kragujevac), Christopher Linington(University of Glasgow), José C. Alves‐Filho(University of Glasgow), Sandra Yasuyo Fukada(University of Glasgow), Miodrag L. Lukić(University of Kragujevac), Dieudonnée Togbe(Université d'Orléans), Damo Xu(University of Glasgow), Carl S. Goodyear(University of California San Diego), Debbie Allan(University of Strathclyde)
Cited by 304
Related Papers
IL-1 family nomenclature
|Nature Immunology|2010|341
Interleukin‐33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
|International Journal of Cancer|2013|326
Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus
|Stem Cells|2010|286
IL-33/ST2 axis in inflammation and immunopathology
|Immunologic Research|2012|259
Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates
|Diabetes Research and Clinical Practice|2007|212